# FDA Inspection 624327 - Carter BloodCare, Inc. - October 14, 2009

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare-inc/38449c02-5b9a-4d80-a6a6-f759a3b349c0
Source feed: FDA_Inspections

> FDA Inspection 624327 for Carter BloodCare, Inc. on October 14, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 624327
- Company Name: Carter BloodCare, Inc.
- Inspection Date: 2009-10-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 883571 - 2014-06-11](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-inc/8e59e60a-709c-42be-a702-48e6e751573b)
- [FDA Inspection 764699 - 2012-01-26](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-inc/a75f6ca8-98d5-48eb-b316-44fccc03f4f3)

Company: https://www.keypedia.com/companies/carter-bloodcare-inc/686b2b82-c133-471d-93e6-08f59d9ca1b1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d